跳至主要内容
临床试验/NL-OMON54713
NL-OMON54713招募中3 期

COLLISION trial - Colorectal liver metastases: surgery versus thermal ablation - a phase III prospective randomized controlled trial - COLLISION - Surgery versus ablation for colorectal liver metastases

Vrije Universiteit Medisch Centrum0 个研究点目标入组 637 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
637

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Histological documentation of primary colorectal tumor;
  • At least one CRLM size <= 3 cm eligible for both surgical resection and
  • thermal ablation (target lesions);
  • Additional unresectable CRLM should be <= 3 cm and ablatable (unresectable
  • Additional unablatable CRLM should be resectable (unablatable lesions);
  • Maximum number of CRLM 10;
  • Resection for resectable lesions considered possible obtaining negative
  • resection margins (R0) and preserving adequate liver reserve
  • Resectability and ablatability should be re-confirmed intra-operatively by US
  • plus full exploration for hepatic, peritoneal and regional lymph node
  • metastases;
  • Age >18 years;
  • Eastern Cooper ative Oncology Group performance status (ECOG) 0-2;
  • American Society of Anesthesiologists (ASA) grade 1-3;
  • Life expectancy of at least 12 weeks;
  • Written informed consent

排除标准

  • Pregnant or breast-feeding subjects. Women of childbearing potential must
  • have a negative pregnancy test performed within 7 days of the start of
  • Immunotherapy <= 6 weeks prior to the procedure;
  • Chemotherapy <= 6 weeks prior to the procedure;
  • Any surgical resection or focal ablative liver therapy for CRLM prior to
  • Severe allergy to contrast media not controlled with premedication;
  • Patients with only one or two small-size (0-3cm) and anatomically
  • deep-seated (defined as requiring major hepatectomy) CRLM in a single liver

研究者

相似试验

COLLISION trial - Colorectal liver metastases:... | 临床试验